Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction

Affiliations

Review

V B Patel et al. J Invasive Cardiol. 2000 Mar.

. 2000 Mar:12 Suppl B:8B-15B.

¹ The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F25, Cleveland, OH 44195, USA.

No abstract available

Similar articles

[Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
Franzosi MG. Franzosi MG. Ital Heart J Suppl. 2001 Sep;2(9):1034-6. Ital Heart J Suppl. 2001. PMID: 11675828 Italian. No abstract available.
[Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Ottani F, Bresciani B, La Vecchia L, Favero L, Fontanelli A, Galvani M. Ottani F, et al. Ital Heart J Suppl. 2002 May;3(5):544-54. Ital Heart J Suppl. 2002. PMID: 12064194 Italian.
Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction.
Moliterno DJ, Topol EJ. Moliterno DJ, et al. Thromb Haemost. 1997 Jul;78(1):214-9. Thromb Haemost. 1997. PMID: 9198156 Review. No abstract available.
Facilitation of thrombolysis in acute myocardial infarction.
Gambhir DS. Gambhir DS. Indian Heart J. 1999 Sep-Oct;51(5):486-8. Indian Heart J. 1999. PMID: 10721636 Review. No abstract available.
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
Pereira H; GUSTO V Investigators. Pereira H, et al. Rev Port Cardiol. 2001 Jun;20(6):687-8. Rev Port Cardiol. 2001. PMID: 11525077 No abstract available.